Barclays Plc - Jan 9, 2023 Form 3 Insider Report for Zura Bio Ltd (ZURA)

Role
10%+ Owner
Signature
Suejean Mott
Stock symbol
ZURA
Transactions as of
Jan 9, 2023
Transactions value $
$0
Form type
3
Date filed
3/31/2023, 04:48 PM
Previous filing
Mar 31, 2023
Next filing
Mar 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ZURA Class A Ordinary Shares, par value $0.0001 per share 2.34M Jan 9, 2023 By Barclays Bank PLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ZURA Redeemable Warrants Jan 9, 2023 Class A Ordinary Share 1.17M $11.50 By Barclays Bank PLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

(a) Beneficially owned Class A ordinary shares and redeemable warrants are comprised in Units, each consisting of one class A ordinary share and one-half of one redeemable warrant (b) Name of Person Filing: (1) Barclays PLC (2) Barclays Bank PLC (controlled by Barclays PLC) (c) Address of Principal Business Office or, if non, Residence: (1) Barclays PLC 1 Churchill Place London, E14 5HP, England (2) Barclays Bank PLC 1 Churchill Place London, E14 5HP, England (d) The redeemable warrants will become exercisable on the later of 30 days after the completion of the issuer's initial business combination and 12 months from the closing of the initial public offering of the issuer's securities. The redeemable warrants will expire five years after the completion of the issuer's initial business combination or earlier upon redemption by or liquidation of the issuer, as described in the prospectus for the issuer's initial public offering.